← Open Payments lookup

AMANDA GIGLIOTTI: Open Payments

NPI 1487149894 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$587 in 33 payments from 11 companies in 2025. Trend: 2023 $804 · 2024 $1,501 · 2025 $587

Food & beverage: $587
CompanyPaymentsAmount
Novo Nordisk Inc12$171
GlaxoSmithKline, LLC.5$105
Abbott Laboratories5$100
Lilly USA, LLC4$64
Astellas Pharma US Inc1$31
BETA BIONICS, INC.1$26
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Exact Sciences Corporation1$20
AstraZeneca Pharmaceuticals LP1$16
Sumitomo Pharma America, Inc.1$15

Products named: TRELEGY ELLIPTA, Ozempic, Wegovy, PROCLAIM, FREESTYLE LIBRE 3, MOUNJARO, Veozah, Rybelsus.

Industry payments across TX — which companies pay providers there.